| John
Armour, Nottingham |
Measuring gene dosage by
multiplex amplifiable probe hybridisation |
| Chris
Barnes, London |
Carrier testing in
childhood: conflict or compromise? |
| Ralf
Baumeister, Munich |
Analysis of neural
function and dysfunction in a C. elegans model |
| Barbara
Carmichael, London |
Fragile X Syndrome –
its impact on families |
| Jean
Laurent Casanova, Paris |
Osteopetrosis,
Lymphedema, Anhidrotic Ectodermal Dysplasia with Immunodeficiency,
and Incontinentia Pigmenti in the Same Kindred |
| Robert
M. Cassidy, Stockholm |
Stem cells and functional
neurogenesis in the adult brain |
| Elena
Cattaneo, Milan |
Dysfunction of huntingtin
in Huntington Disease. |
| Angus
Clarke, Cardiff |
Lessons from the newborn
screening programme in Wales |
| Anne
Marie Codori, Baltimore,
MD |
Genetic Testing for
Hereditary Colorectal Cancer in Children: Long-Term Psychological
Effects |
| Tom
Cooper, Houston, TX |
Molecular mechanisms in
Myotonic Dystrophy (DM1) |
| Francesco
Cucca, Cagliari |
The heritability of Type
1 Diabetes: genetic bases and molecular mechanisms |
| Albert
de la Chapelle, Columbus, OH |
Baschirotto Lecture 2002:
Gene discovery in cancer: who benefits? |
| Michele
De Luca, Rome |
Toward Gene Therapy of
Junctional Epidermolysis Bullosa (JEB) |
| Alexandra
Durr, Paris |
Clinical trials for
Friedreich Ataxia in adults |
| Evan
Eichler, Cleveland, OH |
Recent duplication and
the dynamic mutation of the human genome |
| Claude
Ferec, Brest |
Neonatal
screening for CF: a 13 years experience in Brittany (France) |
| Alain
Fischer, Paris |
Inherited
immunodeficiencies: relevant models for gene therapy |
| R.
Goebbels, Luxembourg |
Role of European
Parliament on human genetics |
| Judith
Goodship, Newcastle |
Cardiac development and
Cardiovascular malformation |
| Christian
Haass, Munich |
Proteolysis and
Alzheimer's Disease |
| Douglas
Higgs, Oxford |
The relationship between
genome organisation and gene expression at a human telomeric region. |
| A.
Hovnanian, Toulouse |
Junctional Epidermolysis
Bullosa: clinical and molecular features |
| Jean-Pierre
Hugot, Paris |
From Crohn Disease to
IBD1 |
| Alec
Jeffreys, Leicester |
Patterns of meiotic
recombination |
| Michel
Koenig, Strasbourg |
Friedreich and other
recessive ataxias |
| Yann
Le Cam, Paris |
The European Orphan Drug
Legislation: Impact and issues |
| Peter
Lichter, Heidelberg |
Molecular karyotyping and
array CGH |
| Hans-Peter
Lipp, Zurich |
The tortuous path from
genotype to phenotype: genes and cognition in mutant mice |
| Anthony
Monaco, Oxford |
The search for autism
susceptibility genes |
| Renate
Paro, Heidelberg |
Chromosomal elements
conferring epigenetic inheritance |
| Marc
Peschanski, Paris |
Repairing and protecting
neurones, a dual goal for cell based therapy to the brain |
| Pierre
Rustin, Paris |
Friedreich's Ataxia:
Insights into the Mechanism and Prospects for a Therapy |
| José
Manuel Soria, Barcelona |
Unravelling the genetics
of thrombosis |
| Michael
Speicher, Munich |
Multicolor FISH in two
and three-dimensions |
| Mike
Stratton, Cambridge |
Cancer gene discovery
following the Human Genome Sequence |
| Ann
Swillen, Leuven |
The study of behavioural
phenotypes : implications for practice and management |
| Tapio
Visakorpi, Tampere |
Molecular genetics of
prostate cancer. |
| Ronald
Wanders, Amsterdam |
Functions
and Biogenesis of Peroxisomes and the Metabolic and Molecular Basis
of Peroximal Disorders |
| Hugh
Watkins, Oxford |
Hypertrophic
Cardiomyopathy: more than just a disease of the sarcomere |
| Jean
Weissenbach, Paris |
Current status of the
human genome sequence and its analysis |
| Paul
Workman, Sutton |
From cancer genomics to
new cancer therapeutics |